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Introduction
Glucocorticoids (GCs)' are widely used as anti-inflammatory, immunosuppressive, and antiallergic agents. Their mode ofac-immune response and of the subsequent inflammatory reaction. In addition to a direct effect on immunocompetent cells, GCs markedly influence the migration of leukocytes, the release of inflammatory mediators and the response to these mediators (1, 2) . Most studies concur to demonstrate that GCs suppress cell-mediated immune responses whereas their effect on B cell function is more variable (1, 3, 4) . The production of polyclonal Ig is significantly increased in the presence ofGCs in vitro (5) (6) (7) . Moreover, as recently reported, GC treatment may differently affect the in vivo IgG and IgA antibody response (8) . Treatment of allergic patients with GCs has either no effect or increases the serum IgE levels in spite of clinical improvement (9-1 1). The effect of GCs on the in vitro synthesis of human IgE has not been documented with the exception of two conflicting studies that examined the influence ofGCs on the spontaneous synthesis of IgE by lymphocytes from allergic patients (12, 13) . Very recently, Sarfati et al. (14) reported, that upon stimulation with both interleukin 4 (IL-4) and hydrocortisone (HC), the peripheral blood mononuclear cells (PBMCs) of patients with chronic lymphocytic leukemia (CLL) could be induced to synthesize monoclonal IgE. The IgE response ofthe B cells of CLL patients was strictly dependent upon the presence of HC; indeed in contrast to normal lymphocytes, the PBMCs of CLL patients did not produce any IgE in response to IL-4 alone. In this study we report that HC strongly increases the in vitro synthesis of IgE by IL-4-stimulated human lymphocytes. The analysis of the cellular mechanisms indicates that the IgEpotentiating effect of HC is strictly monocyte dependent. However and most interestingly, the IgE synthesis induced by costimulation with IL-4 and HC does not require the presence of T cells.
Methods
Reagents HC, testosterone, p-estradiol, progesterone (all from Sigma Chemical Co., St. Louis, MO), and the high-affinity anticorticosteroid RU38486 (kindly provided by Dr IgE-BFs. IgE-BFs were measured by a solid-phase RIA as described previously (19) . Briefly, 96-well microtiter plates were coated with 100 ,l ofanti-CD23 MAb 176 at a concentration of 15 ,ug/ml. After overnight incubation, plates were blocked for 2 h with Hanks' supplemented with FCS, and after washing, 75 gl of the sample was allowed to incubate for 4 h.
The plates were then washed and 75 sl of '251-anti-CD23 MAb 135 (2-3 x 104 cpm/ng) was added to the wells. After overnight incubation, the wells were washed and counted in a gamma counter. The total radioactivity was±300,000 cpm/well and the blank was determined by H-FCS (± 160 cpm). (20-22), we have examined the effect of HC on the expression of these molecules by IL-4-stimulated PBMCs. HC significantly inhibits both the release of IgE-BFs ( Fig. 1 ) and the expression of FcERII (Fig. 2) by IL-4-stimulated lymphocytes; this effect is GC specific. At concentrations of 1 or 10 gM, which are optimal for potentiating IgE synthesis, HC suppresses the production ofIgE-BFs by 40-70%. The residual expression of FcERII (and/or the release of its soluble fragments) is required for an optimal IgE response to IL-4 and HC. Indeed, the IgE response obtained in the presence of HC is markedly suppressed by anti-FcERII MAb but not by the isotype-matched control MAb (Fig. 3) . In HC acts at mtultiple levels in the celluilar interactions leading to the synthesis ofIgE by IL-4-stimulated PBMC. The data in Fig. 4 A indicate that a neutralizing MAb to IL-4 suppresses the IL-4-induced IgE synthesis only when added during the first 4 d of the 12-d culture; at day 6 or after, this antibody has no effect. In contrast, HC (10 jiM) still increases the production of IgE when added at day 6 (Fig. 4 B) , suggesting that HC may still act during the IL-4-independent stage ofthe IgE response. This was confirmed in two-stage cultures where PBMCs are first incubated for 7 d with IL-4, extensively washed, and recultured for another week in the absence of IL-4. The addition of HC to the secondary cultures consistently increases IgE synthesis (Fig.  4 C) . The possible effect of HC during the early stage of the IL-4 stimulation was next examined in washout experiments. In these assays PBMC are first cultured for various periods of time with either IL-4 alone or with IL-4 and HC, the cells are then washed and recultured with IL-4 alone. As seen (Fig. 4 D) , PBMCs exposed to both IL-4 and HC during the first 1-4 d of the culture produce more IgE than control cells exposed to IL-4 alone.
Measurement of[3H]thymidine incorporation
HC potentiates the synthesis ofIgE even in the absence of endogenouis produiction of IFN--y. An obvious explanation of the IgE-potentiating effect of HC is that it suppresses the production of IFN-,y (3) a natural antagonist of IgE synthesis (22 The IgE-potentiating activity ofHC is monocyte dependent. Previous studies have indicated that monocytes are required for an optimal IgE response to IL-4 (23). The complete removal of monocytes from PBMCs (by a two-step procedure described in Methods) strongly reduces the IgE response to IL-4 and completely abrogates the IgE-potentiating activity of HC (Table I) . Both are reconstituted by the addition of adherent cells to the monocyte-depleted PBMCs. Monocytes cannot be replaced by the culture supematant of adherent cells (cultured for 24 or 48 h in culture medium alone, or in the presence of either IL-4, HC (I or 10 ,M) or of both IL-4 and HC) tested at concentrations ranging from 5% to 40% (not shown). The addition of either IL-1 (0.5-5 ng/ml), IL-6 (50-300 U/ml) or a combination of both also fails to restore the IgE-potentiating effect of HC on monocyte-depleted PBMCs (not shown). and HC (Table II) . Reconstitution with T cells restores the responsiveness to IL-4 and further increases the response to IL-4 and HC. The amplifying effect of T cells is completely abrogated by cyclosporine A (Table III). It is of note that the ability of HC to support T cell-independent IgE synthesis may be observed with very low concentrations (1 nM) of HC (not shown).
As a first approach to analyze the permissive effect of HC on the synthesis of IgE by T cell-depleted PBMCs, we have examined the effect of HC on the proliferation ofthese cells. As seen (Fig. 5) 
Discussion
It was recently reported that GCs increase the in vivo production of IL-4 and suppress that of IL-2; most interestingly this was observed with pharmacological as well as with physiological levels of GCs (24) . The present study indicates that GCs markedly increase the synthesis of IgE by human lymphocytes cultured in the presence of IL-4. The significance of these two observations is twofold. First, they explain why the treatment of allergic patients with GCs does not suppress, and may even increase, their IgE antibody production (9-1 1). Secondly, they suggest that stress may favor the production of IgE. Hence, these findings probably explain the significant and transient elevation of serum IgE levels after myocardial infarction (25) . This may also account for earlier observations in rodents that the magnitude of the IgE antibody response is temporally related to diurnal variation in endogenous steroid production (26) . Two observations indicate that the effect of hydrocortisone on IgE synthesis is GC specific and most likely mediated by the HC-GC receptor complex. First, the steroid sex hormones have no influence on the IL-4-induced synthesis of IgE. This finding is ofinterest since it is known that serum IgE levels are influenced by age and sex (27, 28) . Secondly, the IgE-potentiating activity ofHC is inhibited by RU38486, a potent steroid hormone antagonist (29) . The augmenting effect of HC on IgE synthesis by IL-4-stimulated cells is not isotype-specific, and moreover in the absence of IL-4, HC does not induce IgE synthesis whereas it increases the production ofthe other isotypes. The latter phenomenon has been extensively analyzed and shown to involve both cellular interactions between monocytes, CD4+ T cells and B lymphocytes as well as the release of T cell-derived soluble factors induced by GCs (30, 31) . The mechanisms leading to the synthesis of IgE after the addition ofIL-4 to cultures ofhuman PBMCs have been extensively analyzed. Briefly, IL-4 triggers cognate interactions between T and B cells, as a result of which B cells are primed to respond to soluble factors including IL-4 itselfas well as endogenous IL-2, IL-6, and the low molecular weight B-cell growth factor (23, [32] [33] [34] [35] . Another important mechanism is the IL-4-induced suppression of the production of natural antagonists of IgE synthesis such as PGE2 and IFN-y (36, 37) . The present study further indicates that needs to be present only during the first 4-5 d of the 12-d culture in order to elicit the synthesis ofIgE which is most apparent at the end ofthe culture period. Moreover, the results show that HC potentiates the IgE response by acting both in the early (IL-4 dependent) and in the late stage (IL-4 independent) of the IL-4-driven stimulation of PBMCs. This indicates that, as expected from the ubiquity of GC receptors (38) , HC acts at multiple steps ofthe IgE response to IL-4. As a first approach to analyze the IgE-potentiating effect of HC we have examined whether it may be explained by (a) the inhibition of IFN-'y production; (b) a change in the expression of FceRII, and (c) an alteration ofthe cellular interactions required to induce IgE synthesis by IL-4-stimulated PBMCs. To our knowledge, IFN-y, IFN-a, and PGE2 are the only known natural antagonists of the IL-4-induced synthesis of IgE (22) . The inhibitory effect of GCs on the production of IFN-y and ofPGs are well known whereas the influence ofGCs on IFN-a production has not been reported (39, 40) . by itself strongly inhibits IFN-y (36) and PGE2 (37) production, it is unlikely that a major mechanism accounting for the IgE-potentiating effect of HC resides in the suppression of the small residual endogenous production of these agents. Indeed, HC markedly increases the synthesis of IgE by IL-4-stimulated neonatal lymphocytes in the absence of endogenous production of IFN-y.
FcERII and its soluble fragments were reported to play a role in the synthesis of human IgE by IL-4-stimulated lymphocytes and by unstimulated lymphocytes from allergic donors (18, 20, (32) (33) (34) . We here report that after rigorous depletion ofT cells, a strong IgE response is induced by costimulation with and GCs, even when the latter are employed at physiological concentrations (10 nM hydrocortisone). Since GCs are known to inhibit the proliferation of both B and T lymphocytes, it was important to examine whether the IL-4 and HC-induced synthesis of IgE by T cell-depleted PBMCs was accompanied by a wave of cellular proliferation. The data clearly indicate that HC induces a modest but significant increase of DNA synthesis by the IL-4-stimulated T cell-depleted PBMCs. This effect spans from days 6 to 10 and precedes the secretion of IgE which is first detectable at day 10. The enhancing effect ofGCs on DNA synthesis by IL-4-stimulated cells appears to be rather unique since GCs were shown to inhibit the proliferative response of B cells to various stimulants (1). However, more recent studies have shown that CGs interfere mainly with the early rather than with the late stages of B cell activation (4) . In contrast to the present observations, Emilie et al. (44, 48) reported that the enhancing activity of GCs on the IgM/IgG production by Staphylococcus aureus Cowan I and IL-2 activated human T cell-depleted PBMCs was accompanied by a significant albeit incomplete inhibition of DNA synthesis.
Unlike unfractionated PBMCs, T cell-depleted mononuclear cells must be in contact with both and HC, at least for 48 h, in order to synthesize IgE. Hence, in the two-stage cultures, HC must be present together with during the primary cultures, and moreover addition of HC to the secondary cultures has no effect. The cellular and the molecular mechanisms whereby HC and IL-4 stimulate T cell-depleted PBMC to synthesize IgE are currently analyzed in more detail. Since IL-4 is capable to induce a T cell-independent synthesis of IgE in the presence of physiological concentrations of HC, it is possible that this mechanism may also operate in vivo. It may be postulated that during stress, which increases the secretion of cortisol and favors the production of IL-4 (24), bystander B cells (that are not involved in MHC-restricted interactions with T cells) may be induced to differentiate into IgE-producing cells. Finally, it is worth noting that the IgE response of T celldepleted PBMCs may be further increased by the addition of T cells. The amplifying effect ofT cells is abrogated by cyclosporine A, suggesting that it is mediated by T cell-derived lymphokines rather than by direct cell-cell interactions between T and B lymphocytes. Supporting this view are the recent observations indicating that IL-2 and T cell-derived low molecular weight B cell growth factor play an important role in the IL-4-induced IgE response (34) .
